| Financial Year |
March 31 2023 |
| Monetary Funds |
231,183,551.61 |
| Held-for-trading Financial Assets |
60,000,000.00 |
| Notes Receivable |
69,282,755.36 |
| Accounts Receivable |
523,522,145.09 |
| Advances to Suppliers |
62,236,376.68 |
| Other Receivables |
3,659,380.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
391,773,250.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
473,504.78 |
| Total Current Assets |
1,381,737,248.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,493,964.03 |
| Investment Properties |
10,057,661.04 |
| Fixed Assetes |
515,924,235.63 |
| Under-construction Projects |
18,519,990.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,608,585.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
108,341.55 |
| Deferred Income Tax Assets |
9,058,612.58 |
| Other Non-Current Assets |
8,933,265.55 |
| Sub-Total of Non-Current Assets |
716,304,656.37 |
| Total Assets |
2,098,041,904.91 |
| Short-Term Loans |
274,048,616.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
28,875,245.00 |
| Accounts Payable |
110,701,242.68 |
| Accounts Received In Advance |
7,660,694.41 |
| Employee Compensation Payable |
24,666,518.73 |
| Taxes Payable |
8,061,456.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,030,885.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
46,436,658.29 |
| Sub-Total of Current Liabilities |
558,008,701.31 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,295,178.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,175,895.75 |
| Total Liabilities |
569,184,597.06 |
| Paid-In Capital(Or Share Stock) |
938,630,183.00 |
| Capital Surplus |
95,908,578.04 |
| Surplus Reserve |
63,557,319.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
428,182,136.99 |
| Minority Stockholder's Interest |
2,295,190.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,526,562,117.51 |
| Owner's Equity（Stockholder's Equity） |
1,528,857,307.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,098,041,904.91 |
